Logo Logo
Exportieren als [RSS feed] RSS 1.0 [RSS2 feed] RSS 2.0
Gruppiert nach: Dokumententyp | Veröffentlichungsdatum
Anzahl der Publikationen: 89

Zeitschriftenartikel

Parhofer, Klaus G. ORCID logoORCID: https://orcid.org/0000-0001-9873-0412 (2023): Apheresis: What Should a Clinician Know? In: Current Atherosclerosis Reports, Bd. 25, Nr. 3: S. 77-83 [PDF, 652kB]

Sapkota, Bhim Prasad ORCID logoORCID: https://orcid.org/0000-0001-7104-5968; Baral, Kedar Prasad; Rehfuess, Eva A. ORCID logoORCID: https://orcid.org/0000-0002-4318-8846; Parhofer, Klaus G. und Berger, Ursula ORCID logoORCID: https://orcid.org/0000-0002-9809-4177 (2023): Effects of age on non-communicable disease risk factors among Nepalese adults.
In: PLOS ONE 18(6), e0281028 [PDF, 805kB]

Sapkota, Bhim Prasad ORCID logoORCID: https://orcid.org/0000-0001-7104-5968; Baral, Kedar Prasad; Berger, Ursula; Parhofer, Klaus G. und Rehfuess, Eva A. ORCID logoORCID: https://orcid.org/0000-0002-4318-8846 (2022): Health sector readiness for the prevention and control of non-communicable diseases: A multi-method qualitative assessment in Nepal.
In: PLOS ONE 17(9), e0272361 [PDF, 737kB]

Gitt, Anselm K.; Parhofer, Klaus G.; Laufs, Ulrich; Maerz, Winfried; Paar, W. Dieter; Bramlage, Peter und Marx, Nikolaus (2022): Hypercholesterolemia diagnosis, treatment patterns and target achievement in patients with acute coronary syndromes in Germany. In: Clinical Research in Cardiology, Bd. 112: S. 299-311

Laufs, Ulrich; Birkenfeld, Andreas L.; Fraass, Uwe; Hohenstein, Bernd; Siegert, Carsten; Klotsche, Jens; Steinhagen-Thiessen, Elisabeth; Pittrow, David; Dexl, Stefan; Salmen, Sunnhild; Schettler, Volker J. J. und Parhofer, Klaus G. (2022): Novel Insights into the Management of Patients with Very High Cardiovascular Risk Eligible for PCSK9 Inhibitor Treatment: Baseline Findings from the PERI-DYS Study. In: Cardiovascular Drugs and Therapy

Parhofer, Klaus G.; Birkenfeld, Andreas L.; Krone, Wilhelm; Lehrke, Michael; Marx, Nikolaus; Merkel, Martin; Schütt, Katharina S.; Zirlik, Andreas und Müller-Wieland, Dirk (2022): Lipidtherapie bei Patienten mit Diabetes mellitus. In: Diabetologie, Bd. 18, Nr. 4: S. 412-417

Chapman, M. John; Zamorano, Jose L. und Parhofer, Klaus G. (2022): Reducing residual cardiovascular risk in Europe: Therapeutic implications of European medicines agency approval of icosapent ethyl/eicosapentaenoic acid. In: Pharmacology & Therapeutics, Bd. 237, 108172

Merkel, MArtin; Müller-Wieland, Dirk; Laufs, Ulrich und Parhofer, Klaus G. (2022): Triglyzeride – Aktuelle Bewertung als Risikomarker und Therapieziele. In: Deutsche Medizinische Wochenschrift, Bd. 147, Nr. 19: S. 1286-1294

Pirmatova, Dilnoza; Dodkhoeva, Munavvara; Hasbargen, Uwe; Flemmer, Andreas W.; Abdusamatzoda, Zulfiya; Saburova, Khursheda; Salieva, Nasiba; Radzhabova, Surayyo und Parhofer, Klaus G. (2022): Screening for Gestational Diabetes Mellitus and Pregnancy Outcomes: Results from a Multicentric Study in Tajikistan. In: Experimental and Clinical Endocrinology & Diabetes, Bd. 130, Nr. 12: S. 821-827

Parhofer, Klaus G.; Birkenfeld, Andreas L.; Krone, Wilhelm; Lehrke, Michael; Marx, Nikolaus; Merkel, Martin; Schütt, Katharina S.; Zirlik, Andreas und Müller-Wieland, Dirk (2022): Lipidtherapie bei Patienten mit Diabetes mellitus. In: Diabetologie und Stoffwechsel, Bd. 17, Nr. Suppl 2: S316-S322

Miller, Michael; Tokgozoglu, Lale; Parhofer, Klaus G.; Handelsman, Yehuda; Leiter, Lawrence A.; Landmesser, Ulf; Brinton, Eliot A. und Catapano, Alberico L. (2022): Icosapent ethyl for reduction of persistent cardiovascular risk: a critical review of major medical society guidelines and statements. In: Expert Review of Cardiovascular Therapy, Bd. 20, Nr. 8: S. 609-625

Parhofer, Klaus G. (2022): New targets for treating hypertriglyceridemia. In: Current Opinion in Endocrinology Diabetes and Obesity, Bd. 29, Nr. 2: S. 106-111

Macicame, Ivalda; Katzmarzyk, Peter T.; Lauchande, Carlos; Uate, Jorge; Cavele, Nilzio; Manhica, Cremildo; Saathoff, Elmar; Parhofer, Klaus G. und Prista, Antonio (2022): Physical Activity Measured by Pedometer in a Peri-Urban Mozambican Population. In: Journal of Physical Activity & Health, Bd. 19, Nr. 11: S. 777-785

Gitt, Anselm K.; Laufs, Ulrich; Marz, Winfried; Paar, W. Dieter; Bramlage, Peter; Marx, Nikolaus und Parhofer, Klaus G. (2022): Hypercholesterolemia Diagnosis, Treatment Patterns, and 12-Month Target Achievement in Clinical Practice in Germany in Patients with Familial Hypercholesterolemia. In: Journal of Clinical Medicine, Bd. 11, Nr. 13, 3810

Parhofer, Klaus G.; Birkenfeld, Andreas L.; Krone, Wilhelm; Lehrke, Michael; Marx, Nikolaus; Merkel, Martin; Schütt, Katharina S.; Zirlik, Andreas und Müller-Wieland, Dirk (2022): Position Paper on Lipid Therapy in Patients with Diabetes Mellitus. In: Experimental and Clinical Endocrinology & Diabetes, Bd. 130, Nr. SUPPL 1: S117-S122

Lotz-Havla, Amelie S.; Weiß, Katharina; Schiergens, Katharina; Regenauer-Vandewiele, Stephanie; Parhofer, Klaus G.; Christmann, Tara; Böhm, Luise; Havla, Joachim und Maier, Esther M. (10. Dezember 2021): Optical Coherence Tomography to Assess Neurodegeneration in Phenylalanine Hydroxylase Deficiency. In: Frontiers in Neurology, Bd. 12, 780624 [PDF, 8MB]

Lutjohann, Dieter; Stellaard, Frans; Boeluekbasi, Bediha; Kerksiek, Anja; Parhofer, Klaus G. und Laufs, Ulrich (2021): Anti-PCSK 9 antibodies increase the ratios of the brain-specific oxysterol 24S-hydroxycholesterol to cholesterol and to 27-hydroxycholesterol in the serum. In: British Journal of Clinical Pharmacology, Bd. 87, Nr. 11: S. 4252-4261

Macicame, Ivalda; Prista, António; Nhachungue, Sheila; Saathoff, Elmar; Rehfuess, Eva Annette; Parhofer, Klaus G.; Cavele, Nílzio und Manhiça, Cremildo (2021): Social determinants and behaviors associated with overweight and obesity among youth and adults in a peri-urban area of Maputo City, Mozambique. In: Journal of Global Health, Bd. 11, Nr. 04021 [PDF, 1MB]

Parhofer, Klaus G. (2021): Oral Lipid-Lowering Treatments Beyond Statins: Too Old and Outdated or Still Useful? In: Current atherosclerosis reports, Bd. 23, 74 [PDF, 753kB]

Aulinger, Benedikt A.; To Viet, Thuan; Waldmann, Elisa und Parhofer, Klaus G. (2021): Prevalence of the Metabolic Syndrome in Severely Obese Patients Presenting for Bariatric Surgery. In: Digestive Diseases, Bd. 39, Nr. 4: S. 334-340

Folwaczny, Alexander; Waldmann, Elisa; Altenhofer, Julia; Henze, Kerstin und Parhofer, Klaus G. (2021): Postprandial Lipid Metabolism in Normolipidemic Subjects and Patients with Mild to Moderate Hypertriglyceridemia: Effects of Test Meals Containing Saturated Fatty Acids, Mono-Unsaturated Fatty Acids, or Medium-Chain Fatty Acids. In: Nutrients, Bd. 13, Nr. 5, 1737

Parhofer, Klaus G. (2021): Oral Lipid-Lowering Treatments Beyond Statins: Too Old and Outdated or Still Useful? In: Current Atherosclerosis Reports, Bd. 23, Nr. 12, 74

Parhofer, Klaus G.; Birkenfeld, Andreas L.; Krone, Wilhelm; Lehrke, Michael; Marx, Nikolaus; Merkel, Martin; Schuett, Katharina S.; Zirlik, Andreas und Mueller-Wieland, Dirk (2021): Lipidtherapie bei Patienten mit Diabetes mellitus. Eine gemeinsame Stellungnahme der Kommission Fettstoffwechsel sowie der AG Herz und Diabetes der Deutschen Diabetes Gesellschaft (DDG), der Sektion Diabetologie und Stoffwechsel der Deutschen Gesellschaft für Endokrinologie (DGE), der AG Herz und Diabetes der Deutschen Gesellschaft für Kardiologie (DGK) und der gemeinsamen AG Herz – Hormone – Diabetes der DGK, DGE und DDG. In: Diabetologe, Bd. 17, Nr. 3: S. 293-298

Parhofer, Klaus G.; Birkenfeld, Andreas L.; Krone, Wilhelm; Lehrke, Michael; Marx, Nikolaus; Merkel, Martin; Schuett, Katharina S.; Zirlik, Andreas und Mueller-Wieland, Dirk (2021): Lipidtherapie bei Patienten mit Diabetes mellitus – Eine gemeinsame Stellungnahme der Kommission Fettstoffwechsel sowie der AG Herz und Diabetes der Deutschen Diabetes Gesellschaft (DDG), der Sektion Diabetes, Adipositas und Stoffwechsel der Deutschen Gesellschaft für Endokrinologie (DGE), der AG Herz und Diabetes der Deutschen Gesellschaft für Kardiologie (DGK) und der gemeinsamen AG Herz – Hormone – Diabetes der DGK, DGE und DDG. In: Diabetologie und Stoffwechsel, Bd. 16: S312-S318

Chigbu, Chibuike Ogwuegbu; Berger, Ursula; Aniebue, Uzochukwu U. und Parhofer, Klaus G. (2. Dezember 2020): Physical Activity and Outdoor Leisure Time Physical Exercise: A Population Study of Correlates and Hindrances in a Resource-Constrained African Setting. In: Journal of Multidisciplinary Healthcare, Bd. 2020, Nr. 13: S. 1791-1799 [PDF, 314kB]

Georgakis, Marios K.; Malik, Rainer; Anderson, Christopher D.; Parhofer, Klaus G.; Hopewell, Jemma C. und Dichgans, Martin ORCID logoORCID: https://orcid.org/0000-0002-0654-387X (1. Februar 2020): Genetic determinants of blood lipids and cerebral small vessel disease: role of high-density lipoprotein cholesterol. In: Brain, Bd. 143, Nr. 2: S. 597-610 [PDF, 1MB]

Klimek, Annemarie; Baerwald, Christoph; Schwarz, Martin; Rutsch, Frank; Parhofer, Klaus G.; Plöckinger, Ursula; Heddrich-Ellerbrok, Margret; Vom Dahl, Stephan; Schöne, Klaus; Ott, Markus; Lang, Frauke und Hennermann, Julia B. (2020): Everyday Life, Dietary Practices, and Health Conditions of Adult PKU Patients: A Multicenter, Cross-Sectional Study. In: Annals of Nutrition and Metabolism, Bd. 76, Nr. 4: S. 251-258

Parhofer, Klaus G.; Chapman, M. John und Nordestgaard, Borge G. (2020): Efficacy and safety of icosapent ethyl in hypertriglyceridaemia: a recap. In: European Heart Journal Supplements, Bd. 22, Nr. J: J21-J33

Aulinger, Benedikt A.; Perabo, Marta; Seeley, Randy J.; Parhofer, Klaus G. und D'Alessio, David A. (2020): Rapid hepatic metabolism blunts the endocrine action of portally infused GLP-1 in male rats. In: American Journal of Physiology-Endocrinology and Metabolism, Bd. 318, Nr. 2, E189-E197

Laufs, Ulrich; Parhofer, Klaus G.; Ginsberg, Henry N. und Hegele, Robert A. (2020): Clinical review on triglycerides. In: European Heart Journal, Bd. 41, Nr. 1: S. 99-109

Hegele, Robert A.; Boren, Jan; Ginsberg, Henry N.; Arca, Marcello; Averna, Maurizio; Binder, Christoph J.; Calabresi, Laura; Chapman, M. John; Cuchel, Marina; Eckardstein, Arnold von; Frikke-Schmidt, Ruth; Gaudet, Daniel; Hovingh, G. Kees; Kronenberg, Florian; Luetjohann, Dieter; Parhofer, Klaus G.; Raal, Frederick J.; Ray, Kausik K.; Remaley, Alan T.; Stock, Jane K.; Stroes, Erik S.; Tokgozoglu, Lale und Catapano, Alberico L. (2020): Rare dyslipidaemias, from phenotype to genotype to management: a European Atherosclerosis Society task force consensus statement. In: Lancet Diabetes & Endocrinology, Bd. 8, Nr. 1: S. 50-67

Chigbu, Chibuike Ogwuegbu; Aniebue, Uzochukwu U.; Berger, Ursula und Parhofer, Klaus G. (März 2019): Impact of perceptions of body size on obesity and weight management behaviour: a large representative population study in an African setting. In: Journal of Public Health, Bd. 43, Nr. 1, e54-e61

Thompson, Gilbert und Parhofer, Klaus G. (2019): Current Role of Lipoprotein Apheresis. In: Current Atherosclerosis Reports, Bd. 21, Nr. 7, 26

Parhofer, Klaus G. und Laufs, Ulrich (2019): The Diagnosis and Treatment of Hypertriglyceridemia. In: Deutsches Ärzteblatt International, Bd. 116, Nr. 49

Parhofer, Klaus G.; Birkenfeld, Andreas L.; Krone, Wilhelm; Lehrke, Michael; Marx, Nikolaus; Merkel, Martin; Schuett, Katharina S.; Zirlik, Andreas und Müller-Wieland, Dirk (2019): Position Paper on Lipid Therapy in Patients with Diabetes Mellitus. In: Experimental and Clinical Endocrinology & Diabetes, Bd. 127: S97-S101

Parhofer, Klaus G.; Birkenfeld, Andreas L.; Krone, Wilhelm; Lehrke, Michael; Marx, Nikolaus; Merkel, Martin; Schuett, Katharina S.; Zirlik, Andreas und Müller-Wieland, Dirk (2019): Positionspapier zur Lipidtherapie bei Patienten mit Diabetes mellitus. In: Diabetologie und Stoffwechsel, Bd. 14: S226-S231

Parhofer, Klaus G.; Birkenfeld, Andreas L.; Krone, Wilhelm; Lehrke, Michael; Marx, Nikolaus; Merkel, Martin; Schuett, Katharina S.; Zirlik, Andreas und Müller-Wieland, Dirk (2019): Positionspapier zur Lipidtherapie bei Patienten mit Diabetes mellitus. Eine gemeinsame Stellungnahme der Kommission Fettstoffwechsel sowie der AG Herz und Diabetes der Deutschen Diabetes Gesellschaft (DDG), der Sektion Diabetologie und Stoffwechsel der Deutschen Gesellschaft für Endokrinologie (DGE), der AG Herz und Diabetes der Deutschen Gesellschaft für Kardiologie (DGK) und der gemeinsamen AG Herz – Hormone – Diabetes der DGK, DGE und DDG. In: Diabetologe, Bd. 15, Nr. 5: S. 432-436

Waldmann, Elisa und Parhofer, Klaus G. (2019): Apheresis for severe hypercholesterolaemia and elevated lipoprotein(a). In: Pathology, Bd. 51, Nr. 2: S. 227-232

Ma, Louis; Waldmann, Elisa; Ooi, Esther M. M.; Chan, Dick C.; Barrett, Hugh P. R.; Watts, Gerald F. und Parhofer, Klaus G. (2019): Lipoprotein (a) and Low-density lipoprotein apolipoprotein B metabolism following apheresis in patients with elevated lipoprotein(a) and coronary artery disease. In: European Journal of Clinical Investigation, Bd. 49, Nr. 2, UNSP e13053

Packer, Milton; Butler, Javed; Filippatos, Gerasimos S.; Jamal, Waheed; Salsali, Afshin; Schnee, Janet; Kimura, Karen; Zeller, Cordula; George, Jyothis; Brueckmann, Martina; Anker, Stefan D.; Zannad, Faiez; Perrone, Sergio; Nicholls, Stephen; Janssens, Stefan; Bocchi, Edmar; Giannetti, Nadia; Verma, Subodh; Jian, Zhang; Spinar, Jindrich; Seronde, Marie-France; Boehm, Michael; Merkely, Bela; Chopra, Vijay; Senni, Michele; Taddei, Stefano; Tsutsui, Hiroyuki; Choi, Dong-Ju; Chuquiure, Eduardo; La Rocca, Hans Pieter Brunner; Ponikowski, Piotr; Gonzalez Juanatey, Jose Ramon; Squire, Iain; Butler, Javed; Januzzi, James; Pina, Ileana; Pocock, Stuart J.; Carson, Peter; Doehner, Wolfram; Miller, Alan; Haas, Markus; Pehrson, Steen; Komajda, Michel; Anand, Inder; Teerlink, John; Rabinstein, Alejandro; Steiner, Thorsten; Kamel, Hooman; Tsivgoulis, Georgios; Lewis, James; Freston, James; Kaplowitz, Neil; Mann, Johannes; Petrie, Mark; Bernstein, Richard; Cheung, Alfred; Green, Jennifer; Januzzi, James; Kaul, Sanjay; Ping, Carolyn Lam Su; Lip, Gregory; Marx, Nikolaus; McCullough, Peter; Mehta, Cyrus; Ponikowski, Piotr; Rosenstock, Julio; Sattar, Naveed; Scirica, Benjamin; Tsutsui, Hiroyuki; Verma, Subodh; Wanner, Christoph; Welty, Francine K.; Parhofer, Klaus G.; Clayton, Tim; Pedersen, Terje R.; Lees, Kennedy R.; Konstam, Marvin A.; Greenberg, Barry und Palmer, Mike (2019): Evaluation of the effect of sodium-glucose co-transporter 2 inhibition with empagliflozin on morbidity and mortality of patients with chronic heart failure and a reduced ejection fraction: rationale for and design of the EMPEROR-Reduced trial. In: European Journal of Heart Failure, Bd. 21, Nr. 10: S. 1270-1278

Parhofer, Klaus G. (2018): Controversial Issues In The Treatment Of Dyslipidemias In Patients With Diabetes Mellitus. In: Revista De Investigacion Clinica-Clinical and Translational Investigation, Bd. 70, Nr. 5: S. 237-243

Siegrist, Monika; Hanssen, Henner; Lammel, Christoph; Haller, Bernhard; Koch, Anna-Maria; Stemp, Pia; Dandl, Elke; Liestak, Roberta; Parhofer, Klaus G.; Vogeser, Michael und Halle, Martin (2018): Effects of a cluster-randomized school-based prevention program on physical activity and microvascular function (JuvenTUM 3). In: Atherosclerosis, Bd. 278: S. 73-81

Parhofer, Klaus G.; Birkenfeld, Andreas L.; Krone, Wilhelm; Lehrke, Michael; Marx, Nikolaus; Merkel, Martin; Schütt, Katharina S.; Zirlik, Andreas und Müller-Wieland, Dirk (2018): Positionspapier zur Lipidtherapie bei Patienten mit Diabetes mellitus. In: Aktuelle Kardiologie, Bd. 7, Nr. 6: S. 431-435

Parhofer, Klaus G.; Birkenfeld, Andreas L.; Krone, Wilhelm; Lehrke, Michael; Marx, Nikolaus; Merkel, Martin; Schütt, Katharina S.; Zirlik, Andreas und Müller-Wieland, Dirk (2018): Positionspapier zur Lipidtherapie bei Patienten mit Diabetes mellitus. In: Diabetologie und Stoffwechsel, Bd. 13, Nr. Suppl. 2: S209-S213

Bradley, Clare; Eschwege, Eveline; Pablos-Velasco, Pedro de; Parhofer, Klaus G.; Simon, Dominique; Vandenberghe, Hans und Gonder-Frederick, Linda (2018): Predictors of Quality of Life and Other Patient-Reported Outcomes in the PANORAMA Multinational Study of People With Type 2 Diabetes. In: Diabetes Care, Bd. 41, Nr. 2: S. 267-276

Bamberger, Charlotte; Rossmeier, Andreas; Lechner, Katharina; Wu, Liya; Waldmann, Elisa; Fischer, Sandra; Stark, Renee G.; Altenhofer, Julia; Henze, Kerstin und Parhofer, Klaus G. (2018): A Walnut-Enriched Diet Affects Gut Microbiome in Healthy Caucasian Subjects: A Randomized, Controlled Trial. In: Nutrients, Bd. 10, Nr. 2, 244 [PDF, 2MB]

Müller-Wieland, Dirk und Parhofer, Klaus G. (2018): Medikamentöse Therapie von Fettstoffwechselstörungen bei Patienten mit Typ-2-Diabetes. In: Diabetologie und Stoffwechsel, Bd. 13, Nr. 5: S. 403-422

Schmidt, Nina; Dressel, Alexander; Grammer, Tanja B.; Gouni-Berthold, Ioanna; Julius, Ulrich; Kassner, Ursula; Klose, Gerald; König, Christel; König, Wolfgang; Otte, Britta; Parhofer, Klaus G.; Reinhard, Wibke; Schatz, Ulrike; Schunkert, Heribert; Steinhagen-Thiessen, Elisabeth; Vogt, Anja; Laufs, Ulrich und März, Winfried (2018): Lipid-modifying therapy and low-density lipoprotein cholesterol goal attainment in patients with familial hypercholesterolemia in Germany: The CaReHigh Registry. In: Atherosclerosis, Bd. 277: S. 314-322

Waldmann, Elisa; Vogt, Anja; Crispin, Alexander; Altenhofer, Julia; Riks, Ina und Parhofer, Klaus G. (2018): Corrigendum to: “Effect of mipomersen on LDL-cholesterol in patients with severe LDL-hypercholesterolaemia and atherosclerosis treated by lipoprotein apheresis (The MICA-Study)” [Atherosclerosis 259 (2017 Apr) 20–25]. In: Atherosclerosis, Bd. 275: S. 461-462

Chigbu, Chibuike Ogwuegbu; Parhofer, Klaus G.; Aniebue, Uzochukwu U. und Berger, Ursula (2018): Prevalence and sociodemographic determinants of adult obesity: A large representative household survey in a resource-constrained African setting with double burden of undernutrition and overnutrition. In: Journal of epidemiology and community health [PDF, 183kB]

Bamberger, Charlotte; Rossmeier, Andreas; Lechner, Katharina; Wu, Liya; Waldmann, Elisa; Stark, Renee G.; Altenhofer, Julia; Henze, Kerstin und Parhofer, Klaus G. (2017): A Walnut-Enriched Diet Reduces Lipids in Healthy Caucasian Subjects, Independent of Recommended Macronutrient Replacement and Time Point of Consumption: A Prospective, Randomized, Controlled Trial. In: Nutrients, Bd. 9, Nr. 10, 1097 [PDF, 1MB]

Waldmann, Elisa; Vogt, Anja; Crispin, Alexander; Altenhofer, Julia; Riks, Ina und Parhofer, Klaus G. (2017): Effect of mipomersen on LDL-cholesterol in patients with severe LDL-hypercholesterolaemia and atherosclerosis treated by lipoprotein apheresis (The MICA-Study). In: Atherosclerosis, Bd. 259: S. 20-25

Waldmann, Elisa; Bamberger, Charlotte und Parhofer, Klaus G. (2017): Statin intolerance is the main indication for PCSK9 inhibition in clinical practice. In: Atherosclerosis, Bd. 263, E80-E80

Parhofer, Klaus G. (2017): New approaches to address dyslipidemia. In: Current Opinion in Lipidology, Bd. 28, Nr. 6: S. 452-457

Dichgans, Martin; Böhm, Michael; Diener, Hans-Christoph; Hamann, Gerhard F.; Herbst, Heinz-Peter; Minnerup, Jens; Parhofer, Klaus G.; Petzold, Gabor; Schmidtke, Klaus und Zerr, Inga (2017): Vaskuläre Demenzen. In: Aktuelle Neurologie, Bd. 44, Nr. 5: S. 299-311

Kahnert, Kathrin ORCID logoORCID: https://orcid.org/0000-0001-9633-3368; Lucke, Tanja; Huber, Rudolf M.; Behr, Jürgen ORCID logoORCID: https://orcid.org/0000-0002-9151-4829; Biertz, Frank; Vogt, Anja; Watz, Henrik; Alter, Peter; Fähndrich, Sebastian; Bals, Robert; Holle, Rolf; Karrasch, Stefan ORCID logoORCID: https://orcid.org/0000-0001-9807-2915; Sohler, Sandra; Wacker, Margarethe; Ficker, Joachim H.; Parhofer, Klaus G.; Vogelmeier, Claus und Jörres, Rudolf A. ORCID logoORCID: https://orcid.org/0000-0002-9782-1117 (2017): Relationship of hyperlipidemia to comorbidities and lung function in COPD: Results of the COSYCONET cohort.
In: PLOS One 12(5), e0177501 [PDF, 4MB]

März, Winfried; Kleber, Marcus E.; Scharnagl, Hubert; Speer, Timotheus; Zewinger, Stephen; Ritsch, Andreas; Parhofer, Klaus G.; Eckardstein, Arnold von; Landmesser, Ulf und Laufs, Ulrich (2017): HDL cholesterol: reappraisal of its clinical relevance. In: Clinical Research in Cardiology, Bd. 106, Nr. 9: S. 663-675

Stroes, Erik; Moulin, Philippe; Parhofer, Klaus G.; Rebours, Vinciane; Löhr, J.-Matthias und Averna, Maurizio (2017): Diagnostic algorithm for familial chylomicronemia syndrome. In: Atherosclerosis Supplements, Bd. 23: S. 1-7

Lebherz, Corinna; Kahles, Florian; Piotrowski, Katja; Vogeser, Michael; Foldenauer, Ann Christina; Nassau, Kirsten; Kilger, Erich; Marx, Nikolaus; Parhofer, Klaus G. und Lehrke, Michael (2016): Interleukin-6 predicts inflammation-induced increase of Glucagon-like peptide-1 in humans in response to cardiac surgery with association to parameters of glucose metabolism. In: Cardiovascular Diabetology 15:21 [PDF, 843kB]

Waldmann, Elisa und Parhofer, Klaus G. (2016): Thematic Review Series: Lipoprotein (a): Coming of Age at Last Lipoprotein apheresis to treat elevated lipoprotein (a). In: Journal of Lipid Research, Bd. 57, Nr. 10: S. 1751-1757

Parhofer, Klaus G. (2016): The Treatment of Disorders of Lipid Metabolism. In: Deutsches Ärzteblatt international, Bd. 113, Nr. 15: S. 261-268

Parhofer, Klaus G. (2016): Too Many Competing Interests Reply. In: Deutsches Ärzteblatt international, Bd. 113, Nr. 38: S. 643-644

El Khoury, Petra; Waldmann, Elisa; Huby, Thierry; Gall, Julie; Couvert, Philippe; Lacorte, Jean-Marc; Chapman, John; Frisdal, Eric; Lesnik, Philippe; Parhofer, Klaus G.; Le Goff, Wilfried und Guerin, Maryse (2016): Extended-Release Niacin/Laropiprant Improves Overall Efficacy of Postprandial Reverse Cholesterol Transport. In: Arteriosclerosis thrombosis and Vascular Biology, Bd. 36, Nr. 2: S. 285-294

Hooper, Amanda J.; Robertson, Ken; Champain, Danie; Hua, Jianmin; Song, Swithin; Parhofer, Klaus G.; Barrett, P. Hugh R.; Bockxmeer, Frank M. van und Burnett, John R. (2016): Lipoprotein metabolism in an apoB-80 familial hypobetalipoproteinemia heterozygote. In: Clinical Biochemistry, Bd. 49, Nr. 9: S. 720-722

Moriarty, Patrick M.; Parhofer, Klaus G.; Babirak, Stephan P.; Cornier, Marc-Andre; Duell, P. Barton; Hohenstein, Bernd; Leebmann, Josef; Ramlow, Wolfgang; Schettler, Volker; Simha, Vinaya; Steinhagen-Thiessen, Elisabeth; Thompson, Paul D.; Vogt, Anja; Stritzky, Berndt von; Du, Yunling und Manvelian, Garen (2016): Alirocumab in patients with heterozygous familial hypercholesterolaemia undergoing lipoprotein apheresis: the ODYSSEY ESCAPE trial. In: European Heart Journal, Bd. 37, Nr. 48: S. 3588-3595

Bertheau, Robert C.; Bamberg, Fabian; Lochner, Elena; Findeisen, Hannes M.; Parhofer, Klaus G.; Kauczor, Hans-Ulrich; Schoenberg, Stefan O.; Weckbach, Sabine und Schlett, Christopher L. (2016): Whole-Body MR Imaging Including Angiography: Predicting Recurrent Events in Diabetics. In: European Radiology, Bd. 26, Nr. 5: S. 1420-1430

Moriarty, Patrick M.; Parhofer, Klaus G.; Babirak, Stephan P.; deGoma, Emil; Duell, P. Barton; Hohenstein, Bernd; Ramlow, Wolfgang; Simha, Vinaya; Steinhagen-Thiessen, Elisabeth; Thompson, Paul D.; Vogt, Anja; Stritzky, Berndt von; Du, Yunling und Manvelian, Garen (2016): Alirocumab in patients with heterozygous familial hypercholesterolemia undergoing lipoprotein apheresis: Rationale and design of the ODYSSEY ESCAPE trial. In: Journal of Clinical Lipidology, Bd. 10, Nr. 3: S. 627-634

Mola-Schenzle, E; Staffler, A.; Klemme, M.; Pellegrini, F.; Molinaro, G.; Parhofer, Klaus G.; Messner, H.; Schulze, Andreas und Flemmer, A. W. (2015): Clinically stable very low birthweight infants are at risk for recurrent tissue glucose fluctuations even after fully established enteral nutrition. In: Archives of disease in childhood - Fetal and neonatal edition, Bd. 100, Nr. 2: F126-F131 [PDF, 1MB]

Fugmann, Marina; Uhl, Olaf; Hellmuth, Christian; Hetterich, Holger; Kammer, Nora N.; Ferrari, Uta; Parhofer, Klaus G.; Koletzko, Berthold; Seissler, Jochen und Lechner, Andreas (2015): Differences in the Serum Nonesterified Fatty Acid Profile of Young Women Associated with a Recent History of Gestational Diabetes and Overweight/Obesity.
In: PLOS ONE 10(5), e0128001 [PDF, 446kB]

Fugmann, Marina; Breier, Michaela; Rottenkolber, Marietta; Banning, Friederike; Ferrari, Uta; Sacco, Vanessa; Grallert, Harald; Parhofer, Klaus G.; Seissler, Jochen; Clavel, Thomas und Lechner, Andreas (2015): The stool microbiota of insulin resistant women with recent gestational diabetes, a high risk group for type 2 diabetes. In: Scientific Reports, Bd. 5, 13212 [PDF, 820kB]

Parhofer, Klaus G. (2015): Interaction between Glucose and Lipid Metabolism: More than Diabetic Dyslipidemia. In: Diabetes & Metabolism Journal, Bd. 39, Nr. 5: S. 353-362

Navti, Lifoter K.; Ferrari, Uta; Tange, Emmanuel; Bechtold-Dalla Pozza, Susanne und Parhofer, Klaus G. (2014): Contribution of socioeconomic status, stature and birth weight to obesity in Sub-Saharan Africa: cross-sectional data from primary school-age children in Cameroon. In: BMC Public Health 14:320 [PDF, 209kB]

Wu, Liya; Piotrowski, Katja; Rau, Tiina; Waldmann, Elisa; Broedl, Uli C.; Demmelmair, Hans; Koletzko, Berthold; Stark, Renee G.; Nagel, Jutta M.; Mantzoros, Christos S. und Parhofer, Klaus G. (2014): Walnut-enriched diet reduces fasting non-HDL-cholesterol and apolipoprotein B in healthy Caucasian subjects: a randomized controlled cross-over clinical trial. In: Metabolism: clinical and experimental, Bd. 63, Nr. 3: S. 382-391

Watts, Gerald F.; Gidding, Samuel; Wierzbicki, Anthony S.; Toth, Peter P.; Alonso, Rodrigo; Brown, W. Virgil; Bruckert, Eric; Defesche, Joep; Lin, Khoo Kah; Livingston, Michael; Mata, Pedro; Parhofer, Klaus G.; Raal, Frederick J.; Santos, Raul D.; Sijbrands, Eric J. G.; Simpson, William G.; Sullivan, David R.; Susekov, Andrey V.; Tomlinson, Brian; Wiegman, Albert; Yamashita, Shizuya und Kastelein, John J. P. (2014): Integrated Guidance on the Care of Familial Hypercholesterolaemia from the International FH Foundation: Executive Summary. In: European Journal of Preventive Cardiology, Bd. 22, Nr. 7: S. 849-854 [PDF, 136kB]

Piotrowski, Katja; Becker, Melanie; Zugwurst, Julia; Biller-Friedmann, Ingeborg; Spoettl, Gerald; Greif, Martin; Leber, Alexander W.; Becker, Alexander; Laubender, Rüdiger P.; Lebherz, Corinna; Göke, Burkhard; Marx, Nikolaus; Parhofer, Klaus G. und Lehrke, Michael (2013): Circulating concentrations of GLP-1 are associated with coronary atherosclerosis in humans. In: Cardiovascular Diabetology 12:117 [PDF, 178kB]

Waldmann, Elisa; Huettl, Thomas P.; Göke, Burkhard; Lang, Reinhold und Parhofer, Klaus G. (2013): Effect of sleeve gastrectomy on postprandial lipoprotein metabolism in morbidly obese patients. In: Lipids in Health and Disease 12:82 [PDF, 358kB]

Horster, Sophia; Stemmler, H. Joachim; Mandel, Philipp C.; Mueck, Alexander; Tischer, Johanna; Hausmann, Andreas; Parhofer, Klaus G. und Geiger, Sandra (2012): Mortality of Patients with Hematological Malignancy after Admission to the Intensive Care Unit. In: Onkologie, Nr. 10: S. 556-561 [PDF, 251kB]

Dames, Petra; Weise, Michaela; Puff, Ramona; Göke, Burkhard; Parhofer, Klaus G.; Seissler, Jochen und Lechner, Andreas (2012): Suppression of the Nuclear Factor Eny2 Increases Insulin Secretion in Poorly Functioning INS-1E Insulinoma Cells. In: Experimental Diabetes Research, Bd. 2012, 460869 [PDF, 2MB]

Dames, Petra; Puff, Ramona; Weise, Michaela; Parhofer, Klaus G.; Göke, Burkhard; Götz, Magdalena ORCID logoORCID: https://orcid.org/0000-0003-1551-9203; Graw, Jochen; Favor, Jack und Lechner, Andreas (2010): Relative roles of the different Pax6 domains for pancreatic alpha cell development. In: BMC Developmental Biology 10:39 [PDF, 2MB]

Findeisen, Hannes M.; Weckbach, Sabine; Stark, Renee G.; Reiser, Maximilian F.; Schoenberg, Stefan O. und Parhofer, Klaus G. (2010): Metabolic syndrome predicts vascular changes in whole body magnetic resonance imaging in patients with long standing diabetes mellitus. In: Cardiovascular Diabetology 9:44 [PDF, 450kB]

Lehrke, Michael; Greif, Martin; Broedl, Uli C.; Lebherz, Corinna; Laubender, Rüdiger P.; Becker, Alexander; Ziegler, Franz von; Tittus, Janine; Reiser, Maximilian; Becker, Christoph; Göke, Burkhard; Steinbeck, Gerhard; Leber, Alexander W. und Parhofer, Klaus G. (2009): MMP-1 serum levels predict coronary atherosclerosis in humans. In: Cardiovascular Diabetology 8:50 [PDF, 308kB]

Hartl, Wolfgang H.; Jauch, Karl-Walter; Parhofer, Klaus G. und Rittler, Peter (2009): Complications and monitoring - Guidelines on Parenteral Nutrition, Chapter 11. In: German medical science : GMS e-journal, Bd. 7: Doc17 [PDF, 1MB]

Boeck, Stefan; Metzeler, Klaus H.; Hausmann, Andreas; Baumann, Anja; Gallmeier, Eike; Parhofer, Klaus G. und Stemmler, Hans-Joachim (2009): Cisplatin-Based Chemotherapy for Pulmonary Metastasized Germ Cell Tumors of the Testis - Be Aware of Acute Respiratory Distress Syndrome. In: Onkologie, Nr. 3: S. 125-128 [PDF, 111kB]

Broedl, Uli C.; Lebherz, Corinna; Lehrke, Michael; Stark, Renee; Greif, Martin; Becker, Alexander; Ziegler, Franz von; Tittus, Janine; Reiser, Maximilian; Becker, Christoph; Göke, Burkhard; Parhofer, Klaus G. und Leber, Alexander W. (2009): Low adiponectin levels are an independent predictor of mixed and non-calcified coronary atherosclerotic plaques.
In: PLOS ONE 4(3), e4733 [PDF, 112kB]

Lehrke, Michael; Broedl, Uli C.; Biller-Friedmann, Ingeborg M.; Vogeser, Michael; Henschel, Volkmar; Nassau, Kirsten; Goeke, Burkhard; Kilger, Erich und Parhofer, Klaus G. (2008): Serum concentrations of cortisol, interleukin 6, leptin and adiponectin predict stress induced insulin resistance in acute inflammatory reactions. In: Critical Care 12:R157 [PDF, 320kB]

Fraunberger, Peter; Holler, Ernst; Parhofer, Klaus G.; Walli, Autar K. und Seidel, Dietrich (2008): Haben die Konzentrationen von Interleukin 6, Procalcitonin und CRP bei Intensivpatienten während des ersten Fieberanstieges eine prognostische Bedeutung? In: Laboratoriumsmedizin - Journal of Laboratory Medicine, Bd. 32, Nr. 6: S. 434-437 [PDF, 71kB]

Parhofer, Klaus G.; Muenzel, Felix und Krekler, Michael (2007): Effect of the angiotensin receptor blocker irbesartan on metabolic parameters in clinical practice: the DO-IT prospective observational study. In: Cardiovascular Diabetology 6:36 [PDF, 253kB]

Broedl, Uli C.; Lehrke, Michael; Fleischer-Brielmaier, Elisabeth; Tietz, Anne B.; Nagel, Jutta M.; Göke, Burkhard; Lohse, Peter und Parhofer, Klaus G. (2006): Genetic variants of adiponectin receptor 2 are associated with increased adiponectin levels and decreased triglyceride/VLDL levels in patients with metabolic syndrome. In: Cardiovascular Diabetology 5:11 [PDF, 284kB]

Empen, Klaus; Frost, Robert J. A.; Geiss, H. Christian; Otto, Carsten und Parhofer, Klaus G. (2003): Differential effects of fenofibrate versus atorvastatin on the concentrations of E-selectin and vascular cellular adhesion molecule-1 in patients with type 2 diabetes mellitus and mixed hyperlipoproteinemia: a randomized cross-over trial. In: Cardiovascular Diabetology 2:17 [PDF, 260kB]

Diese Liste wurde am Sat Dec 21 20:24:41 2024 CET erstellt.